These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 12268918)
1. [A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives]. Chen JK Shengzhi Yu Biyun; 1987 May; 7(2):11-6. PubMed ID: 12268918 [TBL] [Abstract][Full Text] [Related]
2. Three triphasic oral contraceptives now available in U.S. Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912 [TBL] [Abstract][Full Text] [Related]
3. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of some coagulation tests in women using low dosage oral contraception]. Gramolini R; Perrone G; Calzolari E; Mancone M; Masci A; Materazzi P; Serafini P; Zichella L Patol Clin Ostet Ginecol; 1987; 15(5):307-12. PubMed ID: 12282061 [TBL] [Abstract][Full Text] [Related]
5. [Triella: a French multicenter double blind clinical study]. Castaigne JP Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213 [TBL] [Abstract][Full Text] [Related]
6. [Pros and cons of triphasic oral contraception]. Berdah J Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512 [TBL] [Abstract][Full Text] [Related]
7. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience. Rubio-lotvin B; Ruiz-moreno JA; Gonzalez-ansorena R Adv Contracept Deliv Syst; 1992; 8(1-2):75-88. PubMed ID: 12285566 [TBL] [Abstract][Full Text] [Related]
9. Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation. Merchiers E; Thiery M; Van Kets H; Parewijck W; Defoort P; Martens G Acta Ther; 1990; 16(2):129-38. PubMed ID: 12342969 [TBL] [Abstract][Full Text] [Related]
10. [Oral contraception: disadvantages of estrogen reduction]. Denis C Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238 [TBL] [Abstract][Full Text] [Related]
11. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs. Prema K Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126 [TBL] [Abstract][Full Text] [Related]
13. Study of rigevidon for oral contraception in a family planning clinic in Kota Bahru, Kelantan. Ang Eng Suan ; Karim HA Malays J Reprod Health; 1990 Jun; 8(1):31-7. PubMed ID: 12316342 [TBL] [Abstract][Full Text] [Related]
15. [Preclinical research and development of norethisterone]. Mcguire JL; Hahn DW; Philipps A Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212 [TBL] [Abstract][Full Text] [Related]
16. The choice of the dose of oestrogen in a combined oral contraceptive. Smith M Fertil Contracept; 1978 Apr; 2(2):22-3. PubMed ID: 12336093 [TBL] [Abstract][Full Text] [Related]
17. [Post-coital contraception]. Serfaty D Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207 [TBL] [Abstract][Full Text] [Related]
18. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy. Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A Popul Sci; 1982; (3):157-68. PubMed ID: 12266214 [TBL] [Abstract][Full Text] [Related]